Metastatic Prostate Small Cell Neuroendocrine Carcinoma
3 clinical trials · Condition
◉ Watch Metastatic Prostate Small Cell Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer (NCT04754425) | M.D. Anderson Cancer Center | 2021-07-15 |
Track Metastatic Prostate Small Cell Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.